Waksal Harlan

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$1.07M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Waksal Harlan

According to the SEC Form 4 filings, Waksal Harlan, being in a position of

  1. Executive Chair at Lyra Therapeutics, Inc.,
    оver the last 12 months, has bought 25000 shares for $74,095, and sold 0 shares,
    over all time since 2022-04-12, has bought 261966 shares for $1.07M, and sold 0 shares.

The largest purchase of all time was on 2022-04-12 and amounted to 236966 shares of Lyra Therapeutics, Inc. for $999,997.

Biography of Waksal Harlan

No biography is available at this moment.

2023-11-10PurchaseLyra Therapeutics, Inc.
LYRA
Executive Chair
25,000
0.0498%
$2.96$74,095+11.37%
2022-04-12PurchaseLyra Therapeutics, Inc.
LYRA
Executive Chair
236,966
0.4759%
$4.22$999,997-21.89%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.